2023
DOI: 10.1021/acs.oprd.3c00278
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory Highlights

Andrew Teasdale,
George E. Johnson
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…As we try to reduce harms and manage the environment, it is much more difficult to identify unintended consequences. If we restrict or ban a class of chemicals (e.g., per- and polyfluoroalkyl substances (PFASs)), where in modern life will the effect be felt? Will it still be possible to manufacture a medicine if a PFAS used in the process, or one lining a pipe, cannot be bought?…”
Section: Environmental Challenges For Pharmaceuticals That Could Limi...mentioning
confidence: 99%
“…As we try to reduce harms and manage the environment, it is much more difficult to identify unintended consequences. If we restrict or ban a class of chemicals (e.g., per- and polyfluoroalkyl substances (PFASs)), where in modern life will the effect be felt? Will it still be possible to manufacture a medicine if a PFAS used in the process, or one lining a pipe, cannot be bought?…”
Section: Environmental Challenges For Pharmaceuticals That Could Limi...mentioning
confidence: 99%